MicroRNA-141 Is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: Clinical analysis of 125 patients

Tohoku Journal of Experimental Medicine

Volumn 235, Issue 3, 2015, Pages 161-169

  Zhang, Xiuling ^a   Li, Ping ^a   Rong, Minhua ^b   He, Rongquan ^a   Hou, Xinxi ^a   Xie, You ^a   Chen, Gang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Adenocarcinoma; MicroRNA 141; Non small cell lung cancer; Squamous cell carcinoma; Survival

Indexed keywords

MICRORNA 141; TUMOR MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MIRN141 MICRORNA, HUMAN; PROTEIN KINASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LUNG CARCINOMA; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NON SMALL CELL LUNG CANCER; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; BLOOD; DISEASE COURSE; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; MIDDLE AGED; MUTATION; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84924340294     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.235.161     Document Type: Article

References (43)

1. Asai, N., Ohkuni, Y., Kaneko, N., Yamaguchi, E. & Kubo, A. (2014) Relapsed small cell lung cancer: treatment options and latest developments. Ther. Adv. Med. Oncol., 6, 69-82.
2. Brothers, J.F., Hijazi, K., Mascaux, C., El-Zein, R.A., Spitz, M.R. & Spira, A. (2013) Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. BMC Med., 11, 168.
3. Chen, B., Huang, T., Jiang, J., Lv, L., Li, H. & Xia, S. (2014a) miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF. Mol. Cell. Biochem., 388, 211-218.
4. Chen, G., Kronenberger, P., Teugels, E. & De Greve, J. (2011) Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells. Biol. Proced. Online, 13, 1.
5. Chen, G., Kronenberger, P., Teugels, E., Umelo, I.A. & De Greve, J. (2012) Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med., 10, 28.
6. Chen, G., Kronenberger, P., Teugels, E., Umelo, I.A. & De Greve, J. (2013a) Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents. Biochem. Biophys. Res. Commun., 431, 623-629.
7. Chen, G., Umelo, I.A., Lv, S., Teugels, E., Fostier, K., Kronenberger, P., Dewaele, A., Sadones, J., Geers, C. & De Greve, J. (2013b) miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One, 8, e60317.
8. Chen, X., Wang, X., Ruan, A., Han, W., Zhao, Y., Lu, X., Xiao, P., Shi, H., Wang, R., Chen, L., Chen, S., Du, Q., Yang, H. & Zhang, X. (2014b) miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Clin. Cancer Res., 20, 2617-2630.
9. Dang, Y., Luo, D., Rong, M. & Chen, G. (2013) Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS One, 8, e61054.
10. Dang, Y.W., Zeng, J., He, R.Q., Rong, M.H., Luo, D.Z. & Chen, G. (2014) Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac. J. Cancer Prev., 15, 4969-4976.
11. De Mello, R.A., Araujo, A., Hespanhol, V. & Reis, R.M. (2013) Loci identified through genome-wide association studies and lung cancer risk: is there anything more? Sao Paulo Med. J., 131, 135-136.
12. DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., Alteri, R., Robbins, A.S. & Jemal, A. (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin., 64, 252-271.
13. Di Leva, G., Garofalo, M. & Croce, C.M. (2014) MicroRNAs in cancer. Annu. Rev. Pathol., 9, 287-314.
14. Gazala, S., Pelletier, J.S., Storie, D., Johnson, J.A., Kutsogiannis, D.J. & Bedard, E.L. (2013) A systematic review and metaanalysis to assess patient-reported outcomes after lung cancer surgery. ScientificWorldJournal, 2013, 789625.
15. Gridelli, C., de Marinis, F., Cappuzzo, F., Di Maio, M., Hirsch, F.R., Mok, T., Morgillo, F., Rosell, R., Spigel, D.R., Yang, J.C. & Ciardiello, F. (2014) Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Clin. Lung Cancer, 15, 173-181.
16. Guz, M., Rivero-Muller, A., Okon, E., Stenzel-Bembenek, A., Polberg, K., Slomka, M. & Stepulak, A. (2014) MicroRNAsrole in lung cancer. Dis. Markers, 2014, 218169.
17. Hu, Z., Chen, J., Tian, T., Zhou, X., Gu, H., Xu, L., Zeng, Y., Miao, R., Jin, G., Ma, H., Chen, Y. & Shen, H. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest., 118, 2600-2608.
18. Iuliano, R., Vismara, M.F., Dattilo, V., Trapasso, F., Baudi, F. & Perrotti, N. (2013) The role of microRNAs in cancer susceptibility. Biomed Res. Int., 2013, 591931.
19. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. & Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
20. Kang, S.M. & Lee, H.J. (2014) MicroRNAs in human lung cancer. Exp. Biol. Med. (Maywood), 239, 1505-1513.
21. Kuwabara, K., Matsuda, S., Fushimi, K., Anan, M., Ishikawa, K.B., Horiguchi, H., Hayashida, K. & Fujimori, K. (2009) Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan. Tohoku J. Exp. Med., 217, 29-35.
22. Lauro, S., Onesti, C.E., Righini, R. & Marchetti, P. (2014) The use of bevacizumab in non-small cell lung cancer: an update. Anticancer Res., 34, 1537-1545.
23. Liu, H.Y. & Chen, J. (2011) Polymorphisms in miRNA binding site: new insight into small cell lung cancer susceptibility. Acta Pharmacol. Sin., 32, 1191-1192.
24. Liu, X.G., Zhu, W.Y., Huang, Y.Y., Ma, L.N., Zhou, S.Q., Wang, Y.K., Zeng, F., Zhou, J.H. & Zhang, Y.K. (2012) High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med. Oncol., 29, 618-626.
25. Liu, Y., Ding, Y., Huang, J., Wang, S., Ni, W., Guan, J., Li, Q., Zhang, Y., Ding, Y., Chen, B. & Chen, L. (2014) MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PLoS One, 9, e88393.
26. Mei, Z., He, Y., Feng, J., Shi, J., Du, Y., Qian, L., Huang, Q. & Jie, Z. (2014) MicroRNA-141 promotes the proliferation of nonsmall cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Lett., 588, 3055-3061.
27. Oom, A.L., Humphries, B.A. & Yang, C. (2014) MicroRNAs: novel players in cancer diagnosis and therapies. Biomed. Res. Int., 2014, 959461.
28. Qu, H., Xu, W., Huang, Y. & Yang, S. (2011) Circulating miRNAs: promising biomarkers of human cancer. Asian Pac. J. Cancer Prev., 12, 1117-1125.
29. Ramshankar, V. & Krishnamurthy, A. (2013) Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough. Asian Pac. J. Cancer Prev., 14, 2167-2172.
30. Ritchie, W. & Rasko, J.E. (2014) Refining microRNA target predictions: sorting the wheat from the chaff. Biochem. Biophys. Res. Commun., 445, 780-784.
31. Rong, M., He, R., Dang, Y. & Chen, G. (2014) Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Ups. J. Med. Sci., 119, 19-24.
32. Siegel, R., Ma, J., Zou, Z. & Jemal, A. (2014) Cancer statistics, 2014. CA Cancer J. Clin., 64, 9-29.
33. Skrzypski, M., Czapiewski, P., Goryca, K., Jassem, E., Wyrwicz, L., Pawlowski, R., Rzyman, W., Biernat, W. & Jassem, J. (2014) Prognostic value of microRNA expression in operable non-small cell lung cancer patients. Br. J. Cancer, 110, 991-1000.
34. Tejero, R., Navarro, A., Campayo, M., Vinolas, N., Marrades, R.M., Cordeiro, A., Ruiz-Martinez, M., Santasusagna, S., Molins, L., Ramirez, J. & Monzo, M. (2014) miR-141 and miR-200c as markers of overall survival in early stage nonsmall cell lung cancer adenocarcinoma. PLoS One, 9, e101899.
35. Usui, S., Minami, Y., Shiozawa, T., Iyama, S., Satomi, K., Sakashita, S., Sato, Y. & Noguchi, M. (2013) Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma. Lung Cancer, 82, 407-412.
36. Vageli, D.P., Zaravinos, A., Daniil, Z., Dahabreh, J., Doukas, S.G., Spandidos, D.A., Gourgoulianis, K.I. & Koukoulis, G.K. (2012) hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment. Int. J. Biol. Markers, 27, e400-404.
37. Wang, Y.C., Sung, W.W., Wang, L., Cheng, Y.W., Chen, C.Y., Wu, T.C., Shieh, S.H. & Lee, H. (2013) Different impact of IL10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma. Anticancer Res., 33, 2729-2735.
38. Wu, S.M., Ai, H.W., Zhang, D.Y., Han, X.Q., Pan, Q., Luo, F.L. & Zhang, X.L. (2014) miR-141 targets ZEB2 to suppress HCC progression. Tumour Biol., 35, 9993-9997.
39. Xia, H., Sun, S., Wang, B., Wang, T., Liang, C., Li, G., Huang, C., Qi, D. & Chu, X. (2014a) miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. Int. J. Mol. Sci., 15, 11973-11983.
40. Xia, Y., Wu, Y., Liu, B., Wang, P. & Chen, Y. (2014b) Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC. FEBS Lett., 588, 2238-2245.
41. Zhao, G., Wang, B., Liu, Y., Zhang, J.G., Deng, S.C., Qin, Q., Tian, K., Li, X., Zhu, S., Niu, Y., Gong, Q. & Wang, C.Y. (2013) miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Mol. Cancer Ther., 12, 2569-2580.
42. Zheng, D.J., Yu, G.H., Gao, J.F. & Gu, J.D. (2013) Concomitant EGFR inhibitors combined with radiation for treatment of non-small cell lung carcinoma. Asian Pac. J. Cancer Prev., 14, 4485-4494.
43. Zhou, X., Xia, Y., Su, J. & Zhang, G. (2014) Down-regulation of miR-141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell. Physiol. Biochem., 33, 1003-1012.